Welcome to CDC Stacks | Guidance for measuring colorectal cancer (CRC) screening rates in health system clinics : DP15-1502 Colorectal Cancer Control Program - 43398 | Stephen B. Thacker CDC Library collection
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Guidance for measuring colorectal cancer (CRC) screening rates in health system clinics : DP15-1502 Colorectal Cancer Control Program
  • Published Date:
    2016
Filetype[PDF - 356.75 KB]


Details:
  • Corporate Authors:
    National Center for Chronic Disease Prevention and Health Promotion (U.S.). Division of Cancer Prevention and Control.
  • Description:
    The purpose of this document is to provide the Centers for Disease Control and Prevention’s (CDC) DP15-1502 grantees with Colorectal Cancer Control Program (CRCCP) guidance for measuring baseline and, thereafter, annual colorectal cancer (CRC) screening rates within participating health system clinics.

    CDC has awarded DP15-1502 grants to increase CRC screening rates (priority outcome) among a defined target population within a partner health system, defined geographical area, or disparate population. Grantees implement evidence-based interventions (EBIs) and other (optional) supportive strategies in partnership with health systems to put into place organized screening programs (see Figure). In addition, CRCCP grantees measure and report a baseline screening rate for health systems where implementation is planned, followed by an annual screening rate report.

    A health system partner may include federally qualified health centers (FQHCs), community health centers (CHCs), health care or hospital networks, Indian Health Service (IHS) and local health department clinics, among others. Health systems often have multiple clinics (FQHCs refer to them as sites). Because grantees may intervene with only a subset of these clinics and may have different activities in different clinics, it is important to measure and report a baseline CRC screening rate for every clinic within a health system, rather than for the overall health system, where CRCCP activities are implemented (see Figure). The clinic-level CRC screening rate is updated annually thereafter. These data will allow grantees and CDC to monitor trends in CRC screening rates in all clinics where program activities are implemented and allow better evidence of the impact of the CRCCP.

    Suggested citation: Centers for Disease Control and Prevention. Guidance for Measuring Colorectal Cancer (CRC) Screening Rates in Health System Clinics. Atlanta, GA: US Department of Health and Human Services; 2016.

    guidance_measuring_crc_screening_rates.pdf

  • Supporting Files:
    No Additional Files